Stocks and InvestingStocks and Investing
Wed, January 13, 2021
Tue, January 12, 2021
Mon, January 11, 2021
Sun, January 10, 2021
Fri, January 8, 2021

Anupam Rama Downgraded (SRPT) to Sell and Held Target at $96 on, Jan 8th, 2021


Published on 2024-10-27 15:10:03 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Sell and Held Target at $96 on, Jan 8th, 2021.

Anupam has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Anupam


  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $212 on, Wednesday, October 28th, 2020
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Tuesday, September 15th, 2020